Helix Biotech Biosimilar mRNA Vaccines
What the buyer wrote
Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Helix Biotech Biosimilar mRNA Vaccines
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Work starts
- 1 Dec 2025
- Work ends
- 30 Nov 2027
- Where
- in London
- Kind of work
- Pharmacy and medicines
Who the buyer named
The buyer published a contact address on this notice.